Prognostic Role of Melatonin in the Assessment of the Hypertension Clinical Course

Background: Sleep disorders are one of the most common problems in patients with arterial hypertension (AH). Circadian blood pressure (BP) cycles are most likely associated with the regulatory influence of melatonin. However, in patients with hypertension, if melatonin production decreases there is...

Full description

Bibliographic Details
Main Authors: Andrey V. Budnevsky, Nadezhda V. Rezova, Svetlana A. Kozhevnikova, Nikolai O. Mikhailov, Evgeniy S. Ovsyannikov
Format: Article
Language:English
Published: International Medical Research and Development Corporation 2020-09-01
Series:International Journal of Biomedicine
Subjects:
Online Access:http://ijbm.org/articles/i39/ijbm_10(3)_oa6.pdf
_version_ 1818189852259123200
author Andrey V. Budnevsky
Nadezhda V. Rezova
Svetlana A. Kozhevnikova
Nikolai O. Mikhailov
Evgeniy S. Ovsyannikov
author_facet Andrey V. Budnevsky
Nadezhda V. Rezova
Svetlana A. Kozhevnikova
Nikolai O. Mikhailov
Evgeniy S. Ovsyannikov
author_sort Andrey V. Budnevsky
collection DOAJ
description Background: Sleep disorders are one of the most common problems in patients with arterial hypertension (AH). Circadian blood pressure (BP) cycles are most likely associated with the regulatory influence of melatonin. However, in patients with hypertension, if melatonin production decreases there is no adequate decrease of BP during sleep. The purpose of this study was to analyze the quality of sleep, chronotypes, and clinical, instrumental and laboratory parameters depending on urinary melatonin level (UML) to determine a prognosis for the course of AH in patients with insomnia. Methods and Results: We examined 178 patients with AH and insomnia aged from 30 to 70 years (mean age of 61.3±0.92 years). The AH diagnosis was based on 2018 ESC/ESH Guidelines for the management of arterial hypertension and Russian Society of Cardiology Clinical guidelines – Arterial hypertension in adults (2020). The insomnia diagnosis was based on the international classification of sleep disorders (2005). Using Multiple Regression Analysis, we determined the factors that influence the levels of SBP and DBP in AH patients with insomnia. AH patients with insomnia have a more severe clinical course of the disease, with frequent requests for medical help, altered BP variability, high anxiety level, high depression level and low level of the quality of life. The patients with AH and insomnia have low UML, which correlated with hypertension grade, chronotypes, high systolic and diastolic BP, BMI, high depression level, and low level of the quality of life in the physical and psychological domains. Conclusion: The developed methods for calculating the levels of SBP and DBP, depending on UML, body mass index, depression level, and PSQI, allow reliably evaluating and controlling the BP level in AH patients with insomnia.
first_indexed 2024-12-11T23:49:24Z
format Article
id doaj.art-a00acf6671204207bafc1e7faac55c0a
institution Directory Open Access Journal
issn 2158-0510
2158-0529
language English
last_indexed 2024-12-11T23:49:24Z
publishDate 2020-09-01
publisher International Medical Research and Development Corporation
record_format Article
series International Journal of Biomedicine
spelling doaj.art-a00acf6671204207bafc1e7faac55c0a2022-12-22T00:45:31ZengInternational Medical Research and Development CorporationInternational Journal of Biomedicine2158-05102158-05292020-09-0110323123410.21103/Article10(3)_OA6Prognostic Role of Melatonin in the Assessment of the Hypertension Clinical CourseAndrey V. Budnevsky0Nadezhda V. Rezova1Svetlana A. Kozhevnikova2Nikolai O. Mikhailov3Evgeniy S. Ovsyannikov4Voronezh State Medical University named after N.N. Burdenko; Voronezh, the Russian Federation Voronezh State Medical University named after N.N. Burdenko; Voronezh, the Russian Federation Voronezh State Medical University named after N.N. Burdenko; Voronezh, the Russian Federation Voronezh State Medical University named after N.N. Burdenko; Voronezh, the Russian Federation Voronezh State Medical University named after N.N. Burdenko; Voronezh, the Russian Federation Background: Sleep disorders are one of the most common problems in patients with arterial hypertension (AH). Circadian blood pressure (BP) cycles are most likely associated with the regulatory influence of melatonin. However, in patients with hypertension, if melatonin production decreases there is no adequate decrease of BP during sleep. The purpose of this study was to analyze the quality of sleep, chronotypes, and clinical, instrumental and laboratory parameters depending on urinary melatonin level (UML) to determine a prognosis for the course of AH in patients with insomnia. Methods and Results: We examined 178 patients with AH and insomnia aged from 30 to 70 years (mean age of 61.3±0.92 years). The AH diagnosis was based on 2018 ESC/ESH Guidelines for the management of arterial hypertension and Russian Society of Cardiology Clinical guidelines – Arterial hypertension in adults (2020). The insomnia diagnosis was based on the international classification of sleep disorders (2005). Using Multiple Regression Analysis, we determined the factors that influence the levels of SBP and DBP in AH patients with insomnia. AH patients with insomnia have a more severe clinical course of the disease, with frequent requests for medical help, altered BP variability, high anxiety level, high depression level and low level of the quality of life. The patients with AH and insomnia have low UML, which correlated with hypertension grade, chronotypes, high systolic and diastolic BP, BMI, high depression level, and low level of the quality of life in the physical and psychological domains. Conclusion: The developed methods for calculating the levels of SBP and DBP, depending on UML, body mass index, depression level, and PSQI, allow reliably evaluating and controlling the BP level in AH patients with insomnia.http://ijbm.org/articles/i39/ijbm_10(3)_oa6.pdfarterial hypertensioninsomniachronotypequality of life
spellingShingle Andrey V. Budnevsky
Nadezhda V. Rezova
Svetlana A. Kozhevnikova
Nikolai O. Mikhailov
Evgeniy S. Ovsyannikov
Prognostic Role of Melatonin in the Assessment of the Hypertension Clinical Course
International Journal of Biomedicine
arterial hypertension
insomnia
chronotype
quality of life
title Prognostic Role of Melatonin in the Assessment of the Hypertension Clinical Course
title_full Prognostic Role of Melatonin in the Assessment of the Hypertension Clinical Course
title_fullStr Prognostic Role of Melatonin in the Assessment of the Hypertension Clinical Course
title_full_unstemmed Prognostic Role of Melatonin in the Assessment of the Hypertension Clinical Course
title_short Prognostic Role of Melatonin in the Assessment of the Hypertension Clinical Course
title_sort prognostic role of melatonin in the assessment of the hypertension clinical course
topic arterial hypertension
insomnia
chronotype
quality of life
url http://ijbm.org/articles/i39/ijbm_10(3)_oa6.pdf
work_keys_str_mv AT andreyvbudnevsky prognosticroleofmelatoninintheassessmentofthehypertensionclinicalcourse
AT nadezhdavrezova prognosticroleofmelatoninintheassessmentofthehypertensionclinicalcourse
AT svetlanaakozhevnikova prognosticroleofmelatoninintheassessmentofthehypertensionclinicalcourse
AT nikolaiomikhailov prognosticroleofmelatoninintheassessmentofthehypertensionclinicalcourse
AT evgeniysovsyannikov prognosticroleofmelatoninintheassessmentofthehypertensionclinicalcourse